TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31717931

Group type: EXPERIMENTAL
Intervention: Written physical activity policy implemented for 8 weeks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Surveys and interviews with childcare staff
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Environment and Policy Assessment and Observation Self‐Report tool
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Study-specific questionnaire for childcare providers
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Linear mixed effects models
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Descriptive statistics and thematic analysis
Number of subjects: 8
Study: 28463882

Group type: EXPERIMENTAL
Intervention: ART (emtricitabine/tenofovir disoproxil fumarate + lopinavir/ritonavir) + raltegravir + maraviroc
Number of subjects: 22

Group type: COMPARATOR
Intervention: ART (emtricitabine/tenofovir disoproxil fumarate + lopinavir/ritonavir) + placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ART intensification with raltegravir and maraviroc
Number of subjects: 22
Study: 26133944

Group type: EXPERIMENTAL
Intervention: HA + CS injection
Number of subjects: 57

Group type: COMPARATOR
Intervention: triamcinolone injection
Number of subjects: 57
Study: 24054816

Group type: EXPERIMENTAL
Intervention: London Stroke Carers Training Course (LSCTC)
Number of subjects: 928

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 928
Study: 20861135

Group type: EXPERIMENTAL
Intervention: G-CSF 5 μg/kg b.i.d. subcutaneously for 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 18806100

Group type: EXPERIMENTAL
Intervention: Shea butter blend (SA)
Number of subjects: 17

Group type: COMPARATOR
Intervention: High oleic sunflower oil (HO)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Comparison of meals (SA vs HO)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Shea butter blend (SA) and High oleic sunflower oil (HO)
Number of subjects: 17
Study: 15933223

Group type: EXPERIMENTAL
Intervention: Tdap vaccine (0.5-mL intramuscular dose)
Number of subjects: 4480

Group type: EXPERIMENTAL
Intervention: Tdap vaccine
Number of subjects: 4480

Group type: COMPARATOR
Intervention: Td vaccine (Td)
Number of subjects: 4480
Study: 12534409

Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg p.o.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12764802

Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 42
Study: 8538352

Group type: EXPERIMENTAL
Intervention: Holmium:YAG laser endoscopic sinus surgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional endoscopic instrumentation
Number of subjects: 32
Study: 1678220

Group type: EXPERIMENTAL
Intervention: 60 mg terfenadine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 120 mg terfenadine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 240 mg terfenadine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6781588

Group type: EXPERIMENTAL
Intervention: Early mobilisation with or without physiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immobilisation in plaster‐of‐Paris
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment with minimal bandage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tubigrip support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 0
Study: 31034978

Group type: EXPERIMENTAL
Intervention: EMIG laparoscopic and hysteroscopic simulation systems
Number of subjects: 27
Study: 30616811

Group type: EXPERIMENTAL
Intervention: 12-week cardiac rehabilitation program
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study: 28578210

Group type: EXPERIMENTAL
Intervention: Vaccine refusal vignette
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Vaccine delay vignette
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Social barriers vignette
Number of subjects: 1469

Group type: COMPARATOR
Intervention: Up-to-date vaccines vignette
Number of subjects: 1469
Study: 26041849

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 57
Study: 24135027

Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching
Number of subjects: 12000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 12000
Study: 21236408

Group type: EXPERIMENTAL
Intervention: Stromal hydration
Number of subjects: 30

Group type: COMPARATOR
Intervention: No stromal hydration
Number of subjects: 30
Study: 20020793

Group type: EXPERIMENTAL
Intervention: Initial infiltration of a cartridge of 4% articaine with 1:100,000 epinephrine plus a repeated infiltration of the same anesthetic and dose given 25 minutes following the initial infiltration
Number of subjects: 86

Group type: COMPARATOR
Intervention: Initial infiltration of a cartridge of 4% articaine with 1:100,000 epinephrine plus a mock repeated infiltration given 25 minutes following the initial infiltration
Number of subjects: 86
Study: 16703187

Group type: EXPERIMENTAL
Intervention: IV tirofiban infusion before the lesion was crossed with the guidewire
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard therapy including preprocedural aspirin, ticlopidine, and IV heparin
Number of subjects: 111
Study: 14990647

Group type: EXPERIMENTAL
Intervention: CCI-779 (25, 75, or 250 mg weekly as a 30-minute intravenous infusion)
Number of subjects: 111
Study: 11350112

Group type: EXPERIMENTAL
Intervention: Physical training for 12 weeks
Number of subjects: 12
Study: 9184576

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immune globulin infusions (2 g/kg)
Number of subjects: 10
Study: 8214465

Group type: EXPERIMENTAL
Intervention: Powdered ginger root
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Powdered ginger root, Metoclopramide, Placebo
Number of subjects: 120
Study: 3305592

Group type: EXPERIMENTAL
Intervention: High dose reserpine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31472087

Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation with adjunctive use of enamel matrix derivative (EMD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Alveolar ridge preservation without enamel matrix derivative (EMD)
Number of subjects: 30
Study: 29781043

Group type: EXPERIMENTAL
Intervention: 4 day course of antibiotics (Group 1)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 7 day course of antibiotics (Group 2)
Number of subjects: 70
Study: 27438395

Group type: EXPERIMENTAL
Intervention: Multifaceted strategy including baseline measurements, education, reminders, and optional improvement interventions
Number of subjects: 1964

Group type: COMPARATOR
Intervention: Competitive feedback strategy with baseline measurements and non-anonymous results from other departments
Number of subjects: 1964
Study: 24268723

Group type: EXPERIMENTAL
Intervention: Active cTBS treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 12
Study: 23036896

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily (n=9120)
Number of subjects: 18201

Group type: COMPARATOR
Intervention: Warfarin (target INR 2.0-3.0; n=9081)
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18201
Study: 20519097

Group type: EXPERIMENTAL
Intervention: Topical glucocorticoid (GC) spray treatment for one month
Number of subjects: 80
Study: 17586780

Group type: EXPERIMENTAL
Intervention: Citalopram (20-40 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15141721

Group type: EXPERIMENTAL
Intervention: Systemic doxycycline (SD) alone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Systemic doxycycline (SD) + scaling-root planing (SD+SRP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Local doxycycline (LD) alone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Local doxycycline (LD) + scaling-root planing (LD+SRP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Scaling-root planing (SRP) alone
Number of subjects: 45
Study: 11680657

Group type: COMPARATOR
Intervention: Cadaveric graft
Number of subjects: 79

Group type: COMPARATOR
Intervention: Living-related donor graft
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: IgAN patients
Number of subjects: 79
Study: 9622910

Group type: EXPERIMENTAL
Intervention: Rule-based and exemplar-based categorization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instance frequency
Number of subjects: 0
Study: 7937278

Group type: EXPERIMENTAL
Intervention: Aconiazide tablets 650 mg (containing isoniazid 300 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isoniazid tablets 300 mg
Number of subjects: 12
Study: 3286128

Group type: EXPERIMENTAL
Intervention: tizanidine hydrochloride
Number of subjects: 100

Group type: COMPARATOR
Intervention: baclofen
Number of subjects: 100
Study: 29658989

Group type: EXPERIMENTAL
Intervention: Group self-management education course
Number of subjects: 404

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 404
Study: 27609509

Group type: EXPERIMENTAL
Intervention: Soya milk
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cows' milk
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Soya milk and Cows' milk
Number of subjects: 12
Study: 25218689

Group type: EXPERIMENTAL
Intervention: EMPOWER-PAR intervention (multifaceted chronic disease management strategies)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10
Study: 22451015

Group type: EXPERIMENTAL
Intervention: ConcordantRx instructions
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard instructions
Number of subjects: 202
Study: 20504840

Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control (no adenoidectomy)
Number of subjects: 217
Study: 18210334

Group type: EXPERIMENTAL
Intervention: NuvaRing
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (no contraception)
Number of subjects: 25

Group type: COMPARATOR
Intervention: NuvaRing (healthy women)
Number of subjects: 25
Study: 16175328

Group type: EXPERIMENTAL
Intervention: 2 percent diltiazem ointment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 18
Study: 15492949

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 11337622

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment with early mobilization using a hyperextension brace (n = 47)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Short-segment posterior fixation using VSP or TSRH instrumentation (n = 33)
Number of subjects: 80
Study: 9444298

Group type: EXPERIMENTAL
Intervention: Candesartan alone
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Candesartan plus enalapril
Number of subjects: 770

Group type: COMPARATOR
Intervention: Enalapril alone
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 770

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Candesartan, enalapril, metoprolol
Number of subjects: 770
Study: 8197779

Group type: EXPERIMENTAL
Intervention: Breast conservation consisting of wide breast resection (quadrantectomy) plus radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quadrantectomy alone (without radiotherapy) in women older than 55 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reducing surgery from quadrantectomy to lumpectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Withdrawing radiotherapy
Number of subjects: 0
Study: 3225202

Group type: EXPERIMENTAL
Intervention: Contralateral visual half-field stimulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ipsilateral visual half-field stimulation
Number of subjects: 14
Study: 31376798

Group type: EXPERIMENTAL
Intervention: Bangla version of the Dimensions of Mastery Questionnaire (DMQ-18)
Number of subjects: 206
Study: 28408145

Group type: EXPERIMENTAL
Intervention: Mepilex Ag™
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Acticoat™ with Mepitel™
Number of subjects: 96

Group type: COMPARATOR
Intervention: Acticoat™
Number of subjects: 96
Study: 25187111

Group type: EXPERIMENTAL
Intervention: 4‐STEPS program (self‐regulation based physical activity program)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard care (control condition)
Number of subjects: 91
Study: 24190927

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Nifedipine CR
Number of subjects: 244
Study: 20350955

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 or 15 mg
Number of subjects: 57
Study: 18513345

Group type: EXPERIMENTAL
Intervention: Moving during a 2-hour observation period in bed after coronary angiography
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard regimen (lying still during observation period)
Number of subjects: 1000
Study: 16098575

Group type: EXPERIMENTAL
Intervention: Soft-Start (SS: 100 mW/cm(2) x 10s + 600 mW/cm(2) x 30s)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pulse-Delay (PD: 100 mW/cm(2) x 3s + 3 min wait + 600 mW/cm(2) x 37s)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Conventional (CO: 400 mW/cm(2) x 40s)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Single Bond (SB) adhesive system
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (CE) adhesive system with SS technique
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pulse-Delay (PD) in microhardness test
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Conventional (CO) in microhardness test
Number of subjects: 2
Study: 14597591

Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 123

Group type: COMPARATOR
Intervention: Accelerated tPA
Number of subjects: 123
Study: 10879765

Group type: EXPERIMENTAL
Intervention: PLIF with pedicle screws and TFCs
Number of subjects: 10

Group type: COMPARATOR
Intervention: Anterior discectomy with unilateral cage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Anterior implantation of bilateral TFCs
Number of subjects: 10
Study: 9356027

Group type: EXPERIMENTAL
Intervention: 1.92 micromol (100 microg) Cr as chromium picolinate two times per day
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 9.6 micromol (500 microg) Cr two times per day
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 8249562

Group type: EXPERIMENTAL
Intervention: 10 ml epidural blood patch (EBP)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 10-15 ml epidural blood patch (EBP)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 10 ml and 10-15 ml epidural blood patch (EBP)
Number of subjects: 81
Study: 3861069

Group type: EXPERIMENTAL
Intervention: Extra early contact beginning approximately one-half hour after delivery
Number of subjects: 78

Group type: COMPARATOR
Intervention: Regular contact
Number of subjects: 78
Study: 29870578

Group type: EXPERIMENTAL
Intervention: GSK2330672 (10-180 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 28829936

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26466590

Group type: EXPERIMENTAL
Intervention: Electroacupuncture group
Number of subjects: 87

Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 23635914

Group type: EXPERIMENTAL
Intervention: Lorazepam (1 to 1.5 mg) intravenously
Number of subjects: 398

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 398
Study: 21385882

Group type: EXPERIMENTAL
Intervention: E(dd)→T(dd)→CMF
Number of subjects: 370

Group type: COMPARATOR
Intervention: EC→T
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: DA
Number of subjects: 370

Group type: COMPARATOR
Intervention: No DA
Number of subjects: 370
Study: 19277410

Group type: EXPERIMENTAL
Intervention: DAWN AC computer-assisted dosage program
Number of subjects: 2631

Group type: COMPARATOR
Intervention: Manual dosage by experienced medical staff
Number of subjects: 2631
Study: 18317605

Group type: EXPERIMENTAL
Intervention: Oral contraceptive with estriol (group 2)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Oral contraceptive without estriol (group 1)
Number of subjects: 33
Study: 15164963

Group type: EXPERIMENTAL
Intervention: Ertapenem 1 g daily
Number of subjects: 529

Group type: COMPARATOR
Intervention: Piperacillin-tazobactam 3.375 g Q6H
Number of subjects: 529
Study: 11479053

Group type: EXPERIMENTAL
Intervention: Group education program for type 2 diabetes
Number of subjects: 105
Study: 9777816

Group type: EXPERIMENTAL
Intervention: Enhanced counseling (4 interactive theory-based sessions)
Number of subjects: 5758

Group type: EXPERIMENTAL
Intervention: Brief counseling (2 interactive risk-reduction sessions)
Number of subjects: 5758

Group type: COMPARATOR
Intervention: Didactic messages (2 brief messages typical of current care)
Number of subjects: 5758

Group type: EXPERIMENTAL
Intervention: Both counseling interventions (Enhanced and Brief)
Number of subjects: 5758
Study: 7873470

Group type: EXPERIMENTAL
Intervention: Quinapril treatment for 20 weeks
Number of subjects: 17
Study: 2450255

Group type: EXPERIMENTAL
Intervention: Enoximone (150 mg t.d.s.)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg t.d.s.)
Number of subjects: 13
Study: 30630844

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (INF)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 29299520

Group type: EXPERIMENTAL
Intervention: Inhalation lavender aromatherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard nursing care (Control)
Number of subjects: 100
Study: 25801891

Group type: EXPERIMENTAL
Intervention: Vitamin D (4000 IU, orally given as four gel capsules of 1000 IU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22952305

Group type: EXPERIMENTAL
Intervention: Exercise combined with neuromuscular electrical stimulation (biphasic pulses, at 75 Hz and 250 µs phase duration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Exercise-only group
Number of subjects: 50
Study: 20542923

Group type: EXPERIMENTAL
Intervention: 50 mg TC-1734 (AZD3480)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 19379973

Group type: EXPERIMENTAL
Intervention: 2 arterial grafts (left thoracic artery plus right thoracic artery or left thoracic artery plus radial artery)
Number of subjects: 815

Group type: COMPARATOR
Intervention: 1 arterial graft (control group)
Number of subjects: 815
Study: 17244633

Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 155000
Study: 14750322

Group type: EXPERIMENTAL
Intervention: HCFU for 6 months
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: HCFU for 2 years
Number of subjects: 155
Study: 12795454

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg b.i.d.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 10200896

Group type: EXPERIMENTAL
Intervention: Propranolol (PROP, without ISA, 160 mg q.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pindolol (PIN, with potent ISA, 15 mg q.d.)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PLA, q.d.)
Number of subjects: 30
Study: 7768077

Group type: EXPERIMENTAL
Intervention: 80 mg (R,S)-propranolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg (R)-propranolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg (S)-propranolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg (R,S)-atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg (R)-atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg (S)-atenolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2109980

Group type: EXPERIMENTAL
Intervention: A mixture of amino acids, glucose and lipids
Number of subjects: 15

Group type: COMPARATOR
Intervention: A mixture of amino acids and glucose
Number of subjects: 15
Study: 120091

Group type: EXPERIMENTAL
Intervention: Blow-bottles
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional postoperative pulmonary physiotherapy
Number of subjects: 98
Study: 31965885

Group type: COMPARATOR
Intervention: Placebo Response (PR) measured by TOVA-ACS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo Response (PR) measured by CAARS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TOVA-PR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TOVA-MPH-R
Number of subjects: 0
Study: 31978010

Group type: EXPERIMENTAL
Intervention: Sodium benzoate (400 mg/kg loading dose followed by 200 mg·kg·day maintenance for 5 days)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard medical therapy with placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Sodium benzoate
Number of subjects: 86
Study: 31353457

Group type: EXPERIMENTAL
Intervention: MDZ-NS 5 mg (single dose)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: MDZ-NS 5 mg (second dose if needed)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: MDZ-NS
Number of subjects: 175
Study: 30141210

Group type: EXPERIMENTAL
Intervention: CRT with defibrillator (CRT-D)
Number of subjects: 756
Study: 26818913

Group type: EXPERIMENTAL
Intervention: Mobile phone-based video intervention (5-minute movies)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 300
Study: 24634346

Group type: EXPERIMENTAL
Intervention: AT/IMT (Aerobic Training with Inspiratory Muscle Training)
Number of subjects: 43

Group type: COMPARATOR
Intervention: AT/SHAM (Aerobic Training with Sham Inspiratory Muscle Training)
Number of subjects: 43
Study: 21659435

Group type: EXPERIMENTAL
Intervention: Acetazolamide 2 × 250 mg daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 20659072

Group type: EXPERIMENTAL
Intervention: Assessed condition (n = 152)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Intervention condition (n = 147)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Screened-only condition (n = 147)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Assessment condition (n = 152)
Number of subjects: 446

Group type: COMPARATOR
Intervention: All groups (screened-only, assessed, intervention)
Number of subjects: 446